Evidence map›Paper›PMID 38586045›Full record

ArticlebioRxiv : the preprint server for biology2025

Glutamine catabolism supports amino acid biosynthesis and suppresses the integrated stress response to promote photoreceptor survival.

Moloy T Goswami, Eric Weh, Shubha Subramanya, Katherine M Weh, Hima Bindu Durumutla, Heather Hager, Nicholas Miller, Sraboni Chaudhury, Anthony Andren, Peter Sajjakulnukit and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Moloy T GoswamiDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Eric WehDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Shubha SubramanyaDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Katherine M WehDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Hima Bindu DurumutlaDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Heather HagerDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Nicholas MillerDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Sraboni ChaudhuryDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Anthony AndrenDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Peter SajjakulnukitDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Li ZhangDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Cagri G BesirliDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-7154-2024
Costas A LyssiotisDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-9309-6141
Thomas J WubbenDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
University of Michigan · USCincinnati Children's Hospital Medical Center · US

Funding

VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
Metabolomics CoreP01HL149633 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DICK, GREGORY JAMES · 2020 to 2024
$11.1M
Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic CancerR37CA237421 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Costas Andreas Lyssiotis · 2020 to 2026
$2.6M
Metabolic Reprogramming for Photoreceptor NeuroprotectionR01EY029675 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BESIRLI, CAGRI · 2019 to 2023
$2.1M
Stromal metabolism promotes therapeutic resistance in pancreatic cancerR01CA248160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$2.0M
Targeting metabolic stress to induce pancreatic tumor cell deathR01CA244931 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$1.9M
Glutamine as an alternative fuel source for photoreceptorsK08EY031757 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WUBBEN, THOMAS JOSEPH · 2020 to 2024
$1.2M
NCI NIH HHS R01 CA244931NCI NIH HHS R01 CA248160NCI NIH HHS R37 CA237421NEI NIH HHS K08 EY031757NEI NIH HHS P30 EY007003NEI NIH HHS R01 EY029675NHLBI NIH HHS P01 HL149633
6 · The paper itself

Abstract

Photoreceptor loss results in vision loss in many blinding diseases, and metabolic dysfunction underlies photoreceptor degeneration. So, exploiting photoreceptor metabolism is an attractive strategy to prevent vision loss. Yet, the metabolic pathways that maintain photoreceptor health remain largely unknown. Here, we investigated the dependence of photoreceptors on glutamine (Gln) catabolism. Gln is converted to glutamate via glutaminase (GLS), so mice lacking GLS in rod photoreceptors were generated to inhibit Gln catabolism. Loss of GLS produced rapid rod photoreceptor degeneration. In vivo metabolomic methodologies and metabolic supplementation identified Gln catabolism as critical for glutamate and aspartate biosynthesis. Concordant with this amino acid deprivation, the integrated stress response (ISR) was activated with protein synthesis attenuation, and inhibiting the ISR delayed photoreceptor loss. Furthermore, supplementing asparagine, which is synthesized from aspartate, delayed photoreceptor degeneration. Hence, Gln catabolism is integral to photoreceptor health, and these data reveal a novel metabolic axis in these metabolically-demanding neurons.

Indexed as

glutaminasemetabolismneurodegenerationPhotoreceptor

Identifiers

PMID38586045
PMCPMC10996599
OpenAlexW4393235715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.